In vitro and in vivo porphyrin accumulation by C6 glioma cells after exposure to 5-aminolevulinic acid

Journal of Photochemistry and Photobiology B: Biology

Volumn 45, Issue 2-3, 1998, Pages 160-169

  Stummer, Walter ^a   Stocker, Susanne ^a   Novotny, Alexander ^a   Heimann, Axel ^b   Sauer, Oliver ^b   Kempski, Oliver ^b   Plesnila, Nikolaus ^a   Wietzorrek, Joachim ^a   Reulen, H J ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Aminolevulinic acid; Fluorescence detection; Malignant glioma; Photodynamic therapy; Porphyrins

Indexed keywords

AMINOLEVULINIC ACID; PORPHYRIN; PROTOPORPHYRIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOACCUMULATION; BLOOD BRAIN BARRIER; CELL CULTURE; CELL VOLUME; CHOROID PLEXUS; CONTROLLED STUDY; EDEMA; FLOW CYTOMETRY; FLUORESCENCE; FLUORESCENCE SPECTROSCOPY; GLIOBLASTOMA; GLIOMA CELL; MALE; NONHUMAN; PIA MATER; PRIORITY JOURNAL; STAINING; WHITE MATTER;

AMINOLEVULINIC ACID; ANIMALS; DISEASE MODELS, ANIMAL; GLIOMA; HUMANS; MALE; PHOTOSENSITIZING AGENTS; PROTOPORPHYRINS; RATS; RATS, WISTAR; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 18244419561     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1011-1344(98)00176-6     Document Type: Article

References (40)

1. [1] J. Yoshida, Y. Kajita, T. Wakabayashi, K. Sugita, Long-term follow-up results of 175 patients with malignant glioma: importance of radical tumour resection and postoperative therapy with interferon, ACNU and radiation, Acta Neurochirurg. (Wien) 127 (1994) 55-59.
2. [2] R.C. Rostomily, A.M. Spence, D. Duong, K. McCormick, M. Bland, M.S. Berger, Multimodality management of recurrent adult malignant glioma: results of a phase II multiagent chemotherapy study and analysis of cytoreductive surgery, Neurosurgery 35 (1994) 378-388.
3. [3] J.S. Hill, A.M. Jaye, W.H. Sawyer, G. Morstyn, P.D. Megison, S.S. Stylli, Selective uptake of hematoporphyrin derivative into human cerebral glioma, Neurosurgery 26 (1990) 248-254.
4. [4] A.M. Kaye, G. Morstyn, Photoradiation therapy causing selective tumor kill in a rat glioma model, Neurosurgery 20 (1989) 408-415.
5. [5] E.R. Laws Jr., D.A. Cortese, J.H. Kinsey, R.T. Eagan, R.E. Anderson, Photoradiation therapy in the treatment of malignant brain tumors: a phase I (feasibility) study, Neurosurgery 9 (1981) 672-678.
6. [6] P.J. Muller, B.C. Wilson, Photodynamic therapy of malignant brain tumours, Can. J. Neurol. Sci. 17 (1990) 19-198.
7. [7] H.T. Whelan, M.H. Schmidt, A.D. Segura, T.L. McAuliffe, D.M. Bajic, KJ. Murray, J.E. Moulder, D.R. Strother, J.P. Thomas, G.A. Meyer, The role of photodynamic therapy in posterior fossa brain tumors. A preclinical study in a canine glioma model, J. Neurosurg. 79 (1993) 562-568.
8. [8] H. Kostron, A. Obwegeser, R. Jakober, Photodynamic therapy in neurosurgery: a review, J. Photochem. Photobiol. B: Biol. 36 (1996) 157-168.
9. [9] W. Stummer, C. Goetz, A. Hassan, A. Heimann, O. Kempski, Kinetics of Photofrin II in perifocal brain edema, Neurosurgery 33 (1993) 1075-1082.
10. [10] K.M. Hebeda, J.B. Wolbers, H.J.C. M Sterenborg, W. Kamohorst, J.J.C. van Gemert, H.A.M. van Alphen, Fluorescence localization in tumour and normal brain after intratumoral injection of haematoporphyrin derivative into rat brain tumor, J. Photochem. Photobiol. B: Biol. 27 (1995) 85-92.
11. [11] T.J. Dougherty, M.T. Cooper, T.S. Mang, Cutaneous phototoxic damage in patients receiving Photofrin, Lasers Surg. Med. 20 (1990) 485-488.
12. [12] W.E. Grant, C. Hopper, A.J. MacRobert, M. Speight, S.G. Bown, Photodynamic therapy of oral cancer: photosensitisation with systemic aminolaevulinic acid, Lancet 342 (1993) 147-148.
13. [13] J.C. Kennedy, R.H. Pottier, Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy, J. Photochem. Photobiol. B: Biol. 14 (1992) 275-292.
14. [14] J. Regula, A.J. MacRobert, A. Gorchein, G.A. Buonaccorsi, S.M. Thorpe, G.M. Spencer, A.R. Hatfield, S.G. Bown, Photosensitisation and photodynamic therapy of oesophageal, duodenal and colorectal tumours using 5-aminolaevulinic acid induced protoporphyrin IX -a pilot study, Gut 36 (1995) 67-75.
15. [15] C.S. Loh, D. Vernon, A.J. MacRobert, J. Bedwell, S.G. Bown, S.B. Brown, Endogenous porphyrin distribution induced by 5-aminolaevulinic acid in the tissue layers of the gastrointestinal tract, J. Photochem. Photobiol. B : Biol. 20 (1993) 47-54.
16. [16] C. Rimington, Porphyrin and haem biosynthesis and its control, Act. Med. Scand. 179 (1966) 11-24.
17. [17] D.X.G. Divaris, J.C. Kennedy, R.H. Pottier, Phototoxic damage to sebaceous glands and hair follicles of mice after systemic administration of 5-aminolaevulinic acid correlates with localised protoporphyrin IX fluorescence, Am. J. Pathol. 136 (1990) 891-897.
18. [18] Z. Malik, H. Lugaci, Destruction of erytholeukaemic cells by photoactivation of endogenous porphyrins, Br. J. Cancer 56 (1987) 589-595.
19. [19] R. Van Hilligersberg, J.W.O. Van der Berg, W.J. Kort, O.T. Terpstra, J.H.P. Wilson, Selective accumulation of endogenously produced porphyrins in a liver metastasis model in rats, Gastroenterology 103 (1992) 647-651.
20. [20] L. Lilge, B.C. Wilson, Photodynamic therapy of intracranial tissue: a preclinical comparative study of four different photosensitizers, J. Clin. Laser Med. Surg. 16 (1998) 81-91.
21. [21] O. Kempski, F. Staub, M. Jansen, F. Schödel, A. Baethmann, Glial cell swelling during extracellular acidosis in vitro, Stroke 19 (1988) 385-392.
22. [22] V. Kachel, E. Glossner, E. Kordwig, G. Ruhenstroth-Bauer, Fluvometricell, a combined cell volume and cell fluorescence analyser, J. Histochem. Cytochem. 25 (1977) 804-812.
23. [23] J. Bedwell, A.J. MacRobert, D. Phillips, S.G. Bown, Fluorescence distribution and photodynamic effect of ALA-induced PP IX in the DMH rat colonie tumour model, Br. J. Cancer 65 (1992) 818-824.
24. [24] R.H. Porttier, Y.F.A. Chow, J.-P. LaPlante, T.G. Truscott, J.C. Kennedy, L.A. Beiner, Non-invasive technique for obtaining fluorescence excitation and emission spectra in vivo, Photochem. Photobiol. 44 (1986) 679-687.
25. [25] C.S. Loh, A.J. MacRobert, J. Bedwell, J. Regula, N. Krasner, S.G. Bown, Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy, Br. J. Cancer 68 (1993) 41-51.
26. [26] K. Rick, R. Sroka, H. Stepp, M. Kriegmair, R.M. Huber, K. Jacob, R. Baumgartner, Pharmacokinetics of 5-aminolevulinic acid-induced protoporphyrin IX in skin and blood, J. Photochem. Photobiol. B: Biol.40 (1997) 313-319.
27. [27] C. Daumas-Duport, B. Scheithauer, J. O'Fallon, P. Kelly, Grading of astrocytomas: a simple and reproducible method, Cancer 62 (1988) 2152-2165.
28. [28] L. Terr, L.P. Weiner, An autoradiographic study of δ-aminolaevulinic acid uptake by mouse brain, Exp. Neurol. 79 (1983) 564-568.
29. [29] K.E. Anderson, G.S. Drummond, U. Freddata, M.K. Sardana, S. Sassa, Phorphyrinogenic effects and induction of heme oxygenase in vivo by 5-aminolevulinic acid, Biochim. Biophys. Acta 676 (1981) 289-299.
30. [30] R. Sroka, R. Baumgartner, L. Gossner, T. Sassy, S. Stocker, Fluorometrische Untersuchung der Porphyrinkinetik im Nacktmaus-Tumor-modell nach intravenöser Applikation von 5-Aminolävulinsäure, Lasermedizin 10 (1994) 96-101.
31. [31] H.J. Reulen, R. Graham, M. Spatz, I. Klatzo, The role of pressure gradients and bulk flow in dynamics of vasogenic brain edema, J. Neurosurg. 46 (1977) 24-35.
32. [32] K. Yamada, Y. Wshio, T. Hayakawa, A. Kato, N. Yamada, H. Mogami, Quantitative autoradiographic measurements of blood-brain barrier permeability in the rat glioma model, J. Neurosurg. 57 (1982) 394-398.
33. [33] R. Bashir, F. Hochberg, R. Oot, Regrowth patterns of glioblastoma multiforme relating to planning of interstitial brachytherapy, Neurosurgery 23 (1988) 27-30.
34. [34] B.W. Henderson, W. Vaughan, D.A. Bellnier, H. van Leengoed, P.G. Johnson, A.R. Oseroff, Photosensitization of murine tumor, vasculature and skin by using 5-arninolevulinic acid-induced porphyrin, Photochem. Photobiol. 62 (1995) 780-789.
35. [35] J. Hanania, Z. Malik, The effect of EDTA and serum on endogenous porphyrin accumulation and photodynamic sensitization of human K562 leukemic cells, Cancer Lett. 65 (1992) 127-131.
36. [36] P. Steinbach, H. Weingandt, R. Baumgartner, M. Kriegmair, F. Hofstadter, R. Knuchel, Cellular fluorescence of the endogenous photosensitizer protoporphyrin IX following exposure to 5-aminolevulinic acid, Photochem. Photobiol. 62 (1995) 887-895.
37. [37] W. Stummer, S. Stocker, S. Wagner, H. Stepp, C. Fritsch, C. Goetz, A.E. Goetz, R. Kiefmann, H.J. Reulen, Intraoperative detection of malignant glioma by 5-ALA-induced porphyrin fluorescence, Neurosurgery 42 (1998) 518-526.
38. [38] P.J. Kelly, C. Daumas-Duport, D.B. Kispert, B.A. Kall, B.W. Scheithauer, J.J. Illig, Imaging-based stereotacic serial biopsies in untreated intracranial glial neoplasms, J. Neurosurg. 66 (1987) 865-874.
39. [39] B.C. Devaux, J.R. O'Fallon, P.J. Kelly, Resection, biopsy, and survival in malignant glial neoplasms. A retrospective study of clinical parameters, therapy and outcome, J. Neurosurg. 78 (1993) 767-775.
40. [40] T. Nitta, K. Satto, Prognostic implications of the extent of surgical resection in patients with intracranial malignant gliomas, Cancer 75 (1995) 2727-2731.